Stock Events

Stock Events

Voyageur Pharmaceuticals 

$0.100000
4
+$0.01+5.26% Monday 18:00

Statistics

Day High
0.1
Day Low
0.1
52W High
0.2002
52W Low
0.0033
Volume
5,000
Avg. Volume
4,918
Mkt Cap
17.86M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-31,607.74%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
8,006.41Revenue
-2.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VYYRF. It's not an investment recommendation.
BCE
4
BCE.TO
Amazon
3
AMZN
Enbridge
3
ENB.TO
Bank Of Nova Scotia
3
BNS.TO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its pharmaceutical segment, competes in developing medical products including those in the mineral and healthcare sectors similar to Voyageur Pharmaceuticals.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a major player in the pharmaceutical industry, developing drugs and treatments that may overlap with the mineral-based products offered by Voyageur Pharmaceuticals.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. operates in the pharmaceutical sector, producing health solutions that can compete with the mineral-based pharmaceuticals developed by Voyageur.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline focuses on a broad range of pharmaceutical products, potentially competing in the same healthcare segments as Voyageur Pharmaceuticals.
Novartis
NVS
Mkt Cap293.94B
Novartis AG, with its extensive range of pharmaceutical products, competes in various therapeutic areas that might intersect with Voyageur’s offerings.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie Inc. competes in the global pharmaceutical market, potentially overlapping with Voyageur’s niche in mineral-based pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol-Myers Squibb operates in multiple pharmaceutical areas, which could include competition in sectors targeted by Voyageur Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap1.06T
Eli Lilly and Company develops a wide array of pharmaceutical products that could compete with Voyageur’s specialized mineral-based treatments.
Sanofi
SNY
Mkt Cap104.13B
Sanofi engages in the development and marketing of pharmaceutical products that may compete with the offerings from Voyageur Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca operates globally in various pharmaceutical sectors, potentially competing with Voyageur Pharmaceuticals in certain healthcare markets.

About

Voyageur Pharmaceuticals Ltd. is dedicated to extracting active pharmaceutical ingredients (APIs) from various mineral resources. The firm's strategic objectives include manufacturing radiocontrast compounds derived from barium and iodine, in addition to developing pharmaceuticals that incorporate bromine. The company boasts complete ownership of three barium sulfate deposits in British Columbia, Canada, with two sites offering material suitable for the pharmaceutical barite industry. Furthermore, Voyageur holds stakes in a rich brine project in Utah, USA, which contains high concentrations of iodine, lithium, and bromine. The entity, which was previously named Voyageur Minerals Ltd., adopted its current moniker, Voyageur Pharmaceuticals Ltd., in December 2019. Headquartered in Calgary, Canada, the company operates from this location.
Show more...
CEO
Mr. Brent Willis Bsc.Eng
Employees
6
Country
Canada
ISIN
CA92918C1014

Listings

OTC Link
US
VYYRF
V
CA
VM.V

0 Comments

Share your thoughts

FAQ

What is Voyageur Pharmaceuticals stock price today?▼
The current price of VYYRF is $0.10 USD — it has increased by +5.26% in the past 24 hours. Watch Voyageur Pharmaceuticals stock price performance more closely on the chart.
What is Voyageur Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Voyageur Pharmaceuticals stocks are traded under the ticker VYYRF.
Is Voyageur Pharmaceuticals stock price growing?▼
VYYRF stock has risen by +0% compared to the previous week, the month change is a +53.85% rise, over the last year Voyageur Pharmaceuticals has showed a -33.33% decrease.
What is Voyageur Pharmaceuticals market cap?▼
Today Voyageur Pharmaceuticals has the market capitalization of 17.86M
When is the next Voyageur Pharmaceuticals earnings date?▼
Voyageur Pharmaceuticals is going to release the next earnings report on August 03, 2026.
What is Voyageur Pharmaceuticals revenue for the last year?▼
Voyageur Pharmaceuticals revenue for the last year amounts to 8,006.41 USD.
What is Voyageur Pharmaceuticals net income for the last year?▼
VYYRF net income for the last year is -2.53M USD.
How many employees does Voyageur Pharmaceuticals have?▼
As of July 16, 2026, the company has 6 employees.
In which sector is Voyageur Pharmaceuticals located?▼
Voyageur Pharmaceuticals operates in the Health & Wellness sector.
When did Voyageur Pharmaceuticals complete a stock split?▼
Voyageur Pharmaceuticals has not had any recent stock splits.
Where is Voyageur Pharmaceuticals headquartered?▼
Voyageur Pharmaceuticals is headquartered in Calgary, Canada.